FFA
AMRX icon

Farther Finance Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Farther Finance Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.7K Sell
1,324
-194
-13% -$3.5K ﹤0.01% 3913
2026
Q2 		$26.3K Buy
1,518
+382
+34% +$5.24K ﹤0.01% 3775
2026
Q1 		$14.4K Buy
1,136
+887
+356% +$11.9K ﹤0.01% 3876
2025
Q4 		$3.14K Buy
249
+100
+67% +$1.14K ﹤0.01% 4518
2025
Q3 		$1.49K Buy
149
+139
+1,390% +$1.25K ﹤0.01% 4242
2025
Q2 		$81 Sell
10
-2
-17% -$15 ﹤0.01% 4328
2025
Q1 		$99 Hold
12
– – ﹤0.01% 4062
2024
Q4 		$95 Buy
12
+2
+20% +$17 ﹤0.01% 3790
2024
Q3 		$83 Buy
10
+1
+11% +$8 ﹤0.01% 3810
2024
Q2 		$58 Hold
9
– – ﹤0.01% 3675
2024
Q1 		$54 Hold
9
– – ﹤0.01% 3459
2023
Q4 		$55 Buy
+9
New +$40 ﹤0.01% 3368

Other funds holding AMRX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
SFGP
Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.36B AUM 14.31% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's AMRX Position: Q3 2026 in Review

Farther Finance Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 13% in Q3 2026, selling an estimated $3.5K and leaving 1,324 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3913.

Farther Finance Advisors first reported a position in AMRX in Q4 2023 and has held it in 12 quarters since. 14 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Farther Finance Advisors held 1,324 shares of Amneal Pharmaceuticals worth $26.7K as of Q3 2026.
  • Farther Finance Advisors sold 194 Amneal Pharmaceuticals shares in Q3 2026, an estimated $3.5K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3913 holding.
  • Farther Finance Advisors first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 14 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.